Blatt J, Reaman G H, Levin N, Poplack D G
Blood. 1980 Sep;56(3):380-2.
Purine nucleoside phosphorylase (PNP) activity has been measured in the lymphoblasts of 22 patients with acute lymphoblastic leukemia (ALL) and correlated with routine immunologic cell surface markers. Fourteen of the 22 patients were considered to have non-T, non-B-cell ALL; 8 patients had T-cell disease. The median PNP activity in 21 control samples of normal peripheral blood mononuclear cells was 83 U. The median PNP activity of the non-T, non-B lymphoblasts was 79 U. No statistical difference in PNP activity between these two groups could be discerned (p < 0.37). In contrast, T-cell lymphoblasts demonstrated diminished PNP activity with a median of 38 U. The differences in activity between T lymphoblasts and both non-T, non-B leukemic cells and normal peripheral blood mononuclear cells were significant (p < 0.001 and p < 0.003, respectively). Evaluation of PNP activity provides further evidence of biochemical heterogeneity among immunologic subclasses of ALL.
已对22例急性淋巴细胞白血病(ALL)患者的淋巴母细胞中的嘌呤核苷磷酸化酶(PNP)活性进行了测定,并将其与常规免疫细胞表面标志物相关联。22例患者中有14例被认为患有非T、非B细胞ALL;8例患者患有T细胞疾病。21份正常外周血单个核细胞对照样本中的PNP活性中位数为83 U。非T、非B淋巴母细胞的PNP活性中位数为79 U。这两组之间的PNP活性无统计学差异(p<0.37)。相比之下,T细胞淋巴母细胞的PNP活性降低,中位数为38 U。T淋巴母细胞与非T、非B白血病细胞及正常外周血单个核细胞之间的活性差异显著(分别为p<0.001和p<0.003)。对PNP活性的评估为ALL免疫亚类之间的生化异质性提供了进一步的证据。